Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pinel

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Presse Medicale (Paris, France : 1983)|October 18, 2001
[Role of local immunity in invasive pulmonary aspergillosis]D Aldebert, C Pinel, J P Brion, et al.
Journal of Clinical Microbiology|April 1, 1995
Specific antibody detection in invasive aspergillosis by analytical isoelectrofocusing and immunoblotting methodsV M Hearn, C Pinel, S Blachier, et al.
Journal of Clinical Microbiology|January 5, 2000
Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosisB F Chumpitazi, C Pinel, B Lebeau, et al.
Journal of Personality and Social Psychology|March 16, 2006
Seeing I to I: a pathway to interpersonal connectednessElizabeth C Pinel, Anson E Long, Mark J Landau, et al.
Acta Cytologica|February 10, 2000
Identification of amylase crystalloids in cystic lesions of the parotid glandJ Boutonnat, V Ducros, C Pinel, et al.
Bulletin Du Cancer|February 1, 1993
Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study groupM C Vacher-Lavenu, A Le Tourneau, P Duvillard, et al.
Pathologie-Biologie|June 1, 1991
[Cystic fibrosis and allergic bronchopulmonary aspergillosis]C Pinel, R Grillot, J P Gout, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Annales De Biologie Clinique|October 13, 1999
[Blastocystis hominis: epidemiological and clinical remarks from more than 3,500 stool examinations]C Pinel, C Réjasse, S Picot, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2012
A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancerR Paridaens, O Rixe, M C Pinel, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Presse Medicale (Paris, France : 1983)|October 18, 2001
[Role of local immunity in invasive pulmonary aspergillosis]D Aldebert, C Pinel, J P Brion, et al.
Journal of Clinical Microbiology|April 1, 1995
Specific antibody detection in invasive aspergillosis by analytical isoelectrofocusing and immunoblotting methodsV M Hearn, C Pinel, S Blachier, et al.
Journal of Clinical Microbiology|January 5, 2000
Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosisB F Chumpitazi, C Pinel, B Lebeau, et al.
Journal of Personality and Social Psychology|March 16, 2006
Seeing I to I: a pathway to interpersonal connectednessElizabeth C Pinel, Anson E Long, Mark J Landau, et al.
Acta Cytologica|February 10, 2000
Identification of amylase crystalloids in cystic lesions of the parotid glandJ Boutonnat, V Ducros, C Pinel, et al.
Bulletin Du Cancer|February 1, 1993
Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study groupM C Vacher-Lavenu, A Le Tourneau, P Duvillard, et al.
Pathologie-Biologie|June 1, 1991
[Cystic fibrosis and allergic bronchopulmonary aspergillosis]C Pinel, R Grillot, J P Gout, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Annales De Biologie Clinique|October 13, 1999
[Blastocystis hominis: epidemiological and clinical remarks from more than 3,500 stool examinations]C Pinel, C Réjasse, S Picot, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2012
A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancerR Paridaens, O Rixe, M C Pinel, et al.
Pageof 10